• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - MAPLE GROVE PROMUS ELEMENT? PLUS; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - MAPLE GROVE PROMUS ELEMENT? PLUS; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493911608300
Device Problem Occlusion Within Device (1423)
Patient Problems Angina (1710); Atherosclerosis (1728); Reocclusion (1985)
Event Date 11/20/2014
Event Type  Injury  
Event Description
Same case as mdr id 2134265-2014-07891, mdr id 2134265-2014-07889.(b)(4).It was reported that atherosclerosis, angina and in-stent restenosis (isr) occurred.In (b)(6) 2012, the patient presented due to unstable angina and was referred for cardiac catheterization.Subsequently, index procedure was performed.The target lesion was 90% in-stent restenosis of a previously implanted unspecified stent located in the first obtuse marginal (om) artery and was 6.0 mm long with a reference vessel diameter of 3.00 mm.The lesion was treated with direct placement of a 3.00x8mm promus element¿ plus drug eluting stent, with 0% residual stenosis.One day post procedure, the patient was discharged on aspirin and clopidogrel.In (b)(6) 2014, a 2.25 mm x 16 mm promus drug eluting stent was implanted in the first om artery.In (b)(6) 2014, a 2.5 mm x 16 mm promus drug eluting stent was implanted in the mid left circumflex (lcx) artery.In (b)(6) 2014, the patient presented due to atherosclerotic cardiovascular disease with unstable angina.The patient was hospitalized and was referred for cardiac catheterization.Coronary angiography was performed and revealed 80% isr of the previously placed study stent and the 2.25 x 16 mm promus stent located in 1st om, and 70% isr of the previously placed 2.5 x 16 mm promus stent located in the mid lcx.The 80% isr in first om and the 70% isr in mid lcx were treated with balloon angioplasty with 10% residual stenosis.One day post procedure, the event was considered as resolved and the patient was discharged on aspirin and clopidogrel.
 
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr: it is indicated that the device will not be returned for evaluation.A review of the batch history, historical trending, and similar complaint trending review for the product family will be conducted.If there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT? PLUS
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - MAPLE GROVE
one scimed place
maple grove MN 55311
Manufacturer Contact
linda leimer
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key4343562
MDR Text Key5174087
Report Number2134265-2014-07888
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 12/04/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/18/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/21/2012
Device Model NumberH7493911608300
Device Catalogue Number39116-0830
Device Lot Number0014987604
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/04/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/17/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age63 YR
-
-